Publicacións (253) Publicacións nas que participase algún/ha investigador/a

2019

  1. NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript Analysis

    Molecular Diagnosis and Therapy, Vol. 23, Núm. 5, pp. 627-633

  2. 0.5% 5-Fluorouracil/10% Salicylic Acid for the Treatment of Distal Actinic Keratoses Under Daily Practice Conditions

    Journal of drugs in dermatology : JDD, Vol. 18, Núm. 3, pp. 285-288

  3. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1151-1159

  4. A densidade coa balanza Mohr-Westphal

    Boletín das ciencias, Año 33, Núm. 88, pp. 61-62

  5. A pilot study on the implementation of reflex testing for the diagnosis of active hepatitis C virus infection at two healthcare centres

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 5, pp. 348-349

  6. A survey among dermatologists: diagnostics of superficial fungal infections – what is used and what is needed to initiate therapy and assess efficacy?

    Journal of the European Academy of Dermatology and Venereology, Vol. 33, Núm. 2, pp. 421-427

  7. A1 asynchrony, a potential risk factor for the rupture of anterior communicating artery aneurysms: A computational fluid dynamics study

    Neurocirugia, Vol. 30, Núm. 5, pp. 207-214

  8. ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegaly

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 5, pp. 320-329

  9. Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps

    Gastroenterology, Vol. 156, Núm. 1, pp. 75-87

  10. Actualidad de los Inhibidores de la PCSK9

    Revista Clínica de Medicina de Familia, Vol. 12, Núm. 3, pp. 125-131

  11. Acylcarnitine profile in neonatal hypoxic-ischemic encephalopathy: The value of butyrylcarnitine as a prognostic marker

    Medicine, Vol. 98, Núm. 15, pp. e15221

  12. Adherence to biological therapies in patients with chronic inflammatory arthropathies

    Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139

  13. Adverse outcomes during pregnancy and major congenital malformations in infants of patients with bipolar and schizoaffective disorders treated with antiepileptic drugs: A systematic review

    Psychiatria Polska, Vol. 53, Núm. 2, pp. 223-244

  14. An EGS Monte Carlo model for Varian TrueBEAM treatment units: Commissioning and experimental validation of source parameters

    Physica Medica, Vol. 64, pp. 81-88

  15. Anetoderma and systemic lupus erythematosus: Case report and literature review

    Acta Dermato-Venereologica, Vol. 99, Núm. 3, pp. 335-336

  16. Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel

    Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 298-304

  17. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

  18. Análisis de la proporción de derivaciones potencialmente evitables desde Atención Primaria a Dermatología por lesiones quísticas o tumorales benignas en España. Datos del estudio DIADERM

    Actas dermo-sifiliograficas, Vol. 110, Núm. 8, pp. 659-665

  19. Are reactive C protein and procalcitonin useful for early diagnosis of postoperative intraabdominal infection after pancreaticoduodenectomy for pancreatic cancer?

    Cirugia y Cirujanos (English Edition), Vol. 87, Núm. 6, pp. 662-666

  20. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 1, pp. 22-32